MedTrace Logo

Integrated Whole-Genome Analysis of Hematologic Disorders

NCT01108159 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2018-05-31

No results posted yet for this study

Summary

We will use new technologies to look at the DNA, RNA, proteins, and metabolites in the disease-containing blood, bone marrow, or tissue and normal cells from the skin. Our goal is to analyze all of the genes in the diseased and normal skin sample. By comparing the results of the diseased sample and normal skin cells and the results of the two types of genetic information (DNA and RNA), we should be able to identify genetic changes that are important for the initiation, progression, or treatment response of that particular disorder.

Conditions

Interventions

PROCEDURE

Blood Draw

PROCEDURE

Skin Biopsy

Sponsors & Collaborators

Principal Investigators

  • James L Zehnder · Stanford University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2013-08-02
Completion
2013-08-02

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01108159 on ClinicalTrials.gov